Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistance

Wong, F. et al. Leveraging artificial intelligence in the fight against infectious diseases. Science 381, 164–170 (2023).
Google Scholar
Cesaro, A. et al. Deep learning tools to accelerate antibiotic discovery. Expert Opin. Drug Discov. (2023).
Porto, W. F. et al. In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. Nat. Commun. 9, 1490 (2018).
Google Scholar
Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342–1350, (2023).
Google Scholar
Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688–702.e13 (2020).
Google Scholar
Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226, (2024).
Google Scholar
Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
Google Scholar
de la Fuente-Nunez, C. et al. Antibiotic failure: Beyond antimicrobial resistance. Drug Resistance Updates 71, 101012 (2023).
Google Scholar
Haney, E. F. et al. Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance. Front. Drug Discov. 2, (2022).
Liu, G.-Y. et al. Antimicrobial resistance crisis: could artificial intelligence be the solution? Mil. Med Res 11, 7 (2024).
Google Scholar
Ross, J. et al. Large-scale chemical language representations capture molecular structure and properties. Nat. Mach. Intell. 4, 1256–1264 (2022).
Google Scholar
Ferruz, N. et al. Anniversary AI reflections. Nat. Mach. Intell. 6, 6–12 (2024).
Google Scholar
Safi, Z. et al. Technical aspects of developing chatbots for medical applications: scoping review. J. Med. Internet Res 22, e19127 (2020).
Google Scholar
Miner, A. S. et al. Chatbots in the fight against the COVID-19 pandemic. NPJ Digit. Med. 3, 65 (2020).
Google Scholar
Orsi, M. et al. Can large language models predict antimicrobial peptide activity and toxicity? RSC Med. Chem. 15, 2030–2036 (2024).
Google Scholar
Smith, K. P. et al. Applications of artificial intelligence in clinical microbiology diagnostic. Test. Clin. Microbiol Newsl. 42, 61–70 (2020).
Google Scholar
Su, M.-H. et al. A chatbot using LSTM-based multi-layer embedding for elderly care. in 2017 International Conference on Orange Technologies (ICOT) 70–74 (IEEE, 2017). https://doi.org/10.1109/ICOT.2017.8336091.
Abashev, A. et al. Programming tools for messenger-based chatbot system organization: implication for outpatient and translational medicines. Bionanoscience 7, 403–407 (2017).
Google Scholar
Orsi, M. et al. Using machine learning to predict the antibacterial activity of ruthenium complexes**. Angewandte Chemie International Edition 63, e202317901 (2024).
Swanson, K. et al. Generative AI for designing and validating easily synthesizable and structurally novel antibiotics. Nat. Mach. Intell. 6, 338–353 (2024).
Google Scholar
Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature (2023).
Wan, F. et al. Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nat. Biomed. Eng. (2024).
Wan, F. et al. Machine learning for antimicrobial peptide identification and design. Nat. Rev. Bioeng. (2024).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Google Scholar
Zhou, J. et al. Predicting effects of noncoding variants with deep learning–based sequence model. Nat. Methods 12, 931–934 (2015).
Google Scholar
Rajkomar, A. et al. Scalable and accurate deep learning with electronic health records. NPJ Digit. Med. 1, 18 (2018).
Google Scholar
COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. (2022).
Hutchings, M. I. et al. Antibiotics: past, present and future. Curr. Opin. Microbiol 51, 72–80 (2019).
Google Scholar
Schlander, M. et al. How much does it cost to research and develop a new drug? A systematic review and assessment. Pharmacoeconomics 39, 1243–1269 (2021).
Google Scholar
Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2, 114–122 (2003).
Google Scholar
What is Sepsis? (2022).
Silva, B. N. et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst. Rev. 2018, CD007934, (2013).
Google Scholar
Alowais, S. A. et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med. Educ. 23, 689 (2023).
Google Scholar
Rabaan, A. A. et al. Application of artificial intelligence in combating high antimicrobial resistance rates. Antibiotics 11, 784 (2022).
Google Scholar
Van Steenkiste, T. et al. Accurate prediction of blood culture outcome in the intensive care unit using long short-term memory neural networks. Artif. Intell. Med. 97, 38–43 (2019).
Google Scholar
Litsa, E. E. et al. An end-to-end deep learning framework for translating mass spectra to de-novo molecules. Commun. Chem. 6, 132 (2023).
Google Scholar
Smith, K. P. et al. Automated interpretation of blood culture gram stains by use of a deep convolutional neural network. J. Clin. Microbiol. 56, e01521–17 (2018).
Google Scholar
Zagajewski, A. et al. Deep learning and single-cell phenotyping for rapid antimicrobial susceptibility detection in Escherichia coli. Commun. Biol. 6, 1164 (2023).
Google Scholar
Mather, C. A. et al. Rapid detection of vancomycin-intermediate staphylococcus aureus by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 54, 883–890 (2016).
Google Scholar
Wang, H.-Y. et al. Rapid detection of heterogeneous vancomycin-intermediate staphylococcus aureus based on matrix-assisted laser desorption ionization time-of-flight: using a machine learning approach and unbiased validation. Front. Microbiol. 9, 2393 (2018).
Google Scholar
Weis, C. et al. Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning. Nat. Med. 28, 164–174 (2022).
Google Scholar
Ali, T. et al. Artificial intelligence for antimicrobial resistance prediction: challenges and opportunities towards practical implementation. Antibiotics 12, 523 (2023).
Google Scholar
Nguyen, M. et al. Using machine learning to predict antimicrobial MICs and associated genomic features for nontyphoidal Salmonella. J. Clin. Microbiol 57, e01260–18, (2019).
Google Scholar
Teng, Q. et al. A survey on the interpretability of deep learning in medical diagnosis. Multimed. Syst. 28, 2335–2355 (2022).
Google Scholar
Hakkoum, H. et al. Interpretability in the medical field: A systematic mapping and review study. Appl Soft Comput 117, 108391 (2022).
Google Scholar
Drouin, A. et al. Predictive computational phenotyping and biomarker discovery using reference-free genome comparisons. BMC Genomics 17, 754 (2016).
Google Scholar
Martínez-Agüero, S. et al. Interpretable clinical time-series modeling with intelligent feature selection for early prediction of antimicrobial multidrug resistance. Future Gener. Computer Syst. 133, 68–83 (2022).
Google Scholar
Lundberg, S. et al. A Unified Approach to Interpreting Model Predictions. arXiv preprint arXiv:1705.07874 (2017).
Giacobbe, D. R. et al. Explainable and Interpretable Machine Learning for Antimicrobial Stewardship: Opportunities and Challenges. Clin. Ther. 46, 474–480 (2024).
Google Scholar
Anahtar, M. N. et al. Applications of machine learning to the problem of antimicrobial resistance: an emerging model for translational research. J. Clin. Microbiol. 59, e0126020 (2021).
Google Scholar
Kanjilal, S. et al. A decision algorithm to promote outpatient antimicrobial stewardship for uncomplicated urinary tract infection. Sci. Transl. Med. 12, eaay5067 (2020).
Google Scholar
Yelin, I. et al. Personal clinical history predicts antibiotic resistance of urinary tract infections. Nat. Med. 25, 1143–1152 (2019).
Google Scholar
Clark M. et al. Chatbots in Health Care: Connecting Patients to Information: Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (2024).
Vijayan, A. et al. A Framework for Intelligent Learning Assistant Platform Based on Cognitive Computing for Children with Autism Spectrum Disorder. in 2018 International CET Conference on Control, Communication, and Computing (IC4) 361–365 (IEEE, 2018). https://doi.org/10.1109/CETIC4.2018.8530940.
Morris, R. R. et al. Towards an artificially empathic conversational agent for mental health applications: System design and user perceptions. J. Med Internet Res 20, e10148 (2018).
Google Scholar
Kadariya, D. et al. kBot: Knowledge-Enabled Personalized Chatbot for Asthma Self-Management. in 2019 IEEE International Conference on Smart Computing (SMARTCOMP) 138–143 (IEEE, 2019). https://doi.org/10.1109/SMARTCOMP.2019.00043.
Aljameel, S. S. et al. Development of an Arabic Conversational Intelligent Tutoring System for Education of children with ASD. in 2017 IEEE International Conference on Computational Intelligence and Virtual Environments for Measurement Systems and Applications (CIVEMSA) 24–29 (IEEE, 2017). https://doi.org/10.1109/CIVEMSA.2017.7995296.
Martínez-Miranda, J. et al. Assessment of users’ acceptability of a mobile-based embodied conversational agent for the prevention and detection of suicidal behaviour. J. Med Syst. 43, 246 (2019).
Google Scholar
What have we done so far? Centers for Disease Control and Prevention, Office of Public Health Data, Surveillance, and Technology (2024). Last Reviewed: April 23, 2024. https://archive.cdc.gov/www_cdc_gov/surveillance/data-modernization/basics/what-have-we-done-so-far.html.
Naik, N. et al. Legal and ethical consideration in artificial intelligence in healthcare: who takes responsibility? Front Surg. 9, 862322 (2022).
Google Scholar
Ghanem, M. et al. Artificial intelligence and personalized medicine: transforming patient care. in The New Era of Precision Medicine 131–142 (Elsevier, 2024). https://doi.org/10.1016/B978-0-443-13963-5.00012-1.
Bouderhem, R. Shaping the future of AI in healthcare through ethics and governance. Humanit Soc. Sci. Commun. 11, 416 (2024).
Google Scholar
Ueda, D. et al. Fairness of artificial intelligence in healthcare: review and recommendations. Jpn J. Radio. 42, 3–15 (2024).
Google Scholar
Rehman, A. U. et al. Role of artificial intelligence in revolutionizing drug discovery. Fundamental Res. (2024).
Chenthamarakshan, V. et al. Accelerating drug target inhibitor discovery with a deep generative foundation model. Sci. Adv. 9, eadg7865 (2023).
Google Scholar
Grisoni, F. et al. Combining generative artificial intelligence and on-chip synthesis for de novo drug design. Sci. Adv. 7, eabg3338 (2021).
Google Scholar
Merk, D. et al. De novo design of bioactive small molecules by artificial intelligence. Mol. Inf. 37, 1700153 (2018).
Google Scholar
Zhavoronkov, A. et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat. Biotechnol. 37, 1038–1040 (2019).
Google Scholar
Das, P. et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat. Biomed. Eng. 5, 613–623 (2021).
Google Scholar
Cesaro, A. et al. Advanced delivery systems for peptide antibiotics. Adv. Drug Del. Rev. (2023).
Miethke, M. et al. Towards the sustainable discovery and development of new antibiotics. Nat. Rev. Chem. 5, 726–749 (2021).
Google Scholar
Li, J. et al. Membrane active antimicrobial peptides: translating mechanistic insights to design. Front Neurosci. 11, 73 (2017).
Google Scholar
Cesaro, A. et al. Synthetic antibiotic derived from sequences encrypted in a protein from human plasma. ACS Nano 16, 1880–1895 (2022).
Google Scholar
Shatri G. et al. Polymyxin. StatPearls (2024).
Nguyen R. et al. Bacitracin Topical. StatPearls (2024).
Hansch, C. et al. Correlation of biological activity of phenoxyacetic acids with hammett substituent constants and partition coefficients. Nature 194, 178–180 (1962).
Google Scholar
Huang, J. et al. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nat. Biomed. Eng. 7, 797–810 (2023).
Google Scholar
Santos-Júnior, C. D. et al. Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell 187, 3761–3778.e16, (2024).
Google Scholar
Capecchi, A. et al. Machine learning designs non-hemolytic antimicrobial peptides. Chem. Sci. 12, 9221–9232 (2021).
Google Scholar
Torkamannia, A. et al. A review of machine learning approaches for drug synergy prediction in cancer. Brief. Bioinform. (2022).
Mayr, A. et al. Large-scale comparison of machine learning methods for drug target prediction on ChEMBL. Chem. Sci. 9, 5441–5451 (2018).
Google Scholar
Bhadra, P. et al. AmPEP: Sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest. Sci. Rep. 8, 1697 (2018).
Google Scholar
Wu, Z. et al. MoleculeNet: a benchmark for molecular machine learning. Chem. Sci. 9, 513–530 (2018).
Google Scholar
Krenn, M. et al. Self-referencing embedded strings (SELFIES): A 100% robust molecular string representation. Mach. Learn Sci. Technol. 1, 045024 (2020).
Google Scholar
Schütt, K. T. et al. SchNet – A deep learning architecture for molecules and materials. J. Chem. Phys. 148, 241722 (2018).
Google Scholar
Ma, Y. et al. Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nat. Biotechnol. 40, 921–931 (2022).
Google Scholar
Jin, W. et al. Multi-Objective Molecule Generation using Interpretable Substructures. in 37th International Conference on Machine Learning, ICML 2020 vols PartF168147-7 (2020).
Torres, M. D. T. et al. Mining for encrypted peptide antibiotics in the human proteome. Nat. Biomed. Eng. 6, 1451–1451 (2022).
Google Scholar
Torres, M. D. T. et al. Mining human microbiomes reveals an untapped source of peptide antibiotics. Cell, press 187, 5453–5467.e15 (2024).
Google Scholar
Maasch, J. R. M. A. et al. Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning. Cell Host Microbe 31, 1260–1274.e6 (2023).
Google Scholar
Cesaro, A. et al. Antibiotic identified by AI. Nat. Chem. Biol. 19, 1296–1298 (2023).
Google Scholar
Sterling, T. et al. ZINC 15 – Ligand discovery for everyone. J. Chem. Inf. Model 55, 2324–2337 (2015).
Google Scholar
Bateman, A. et al. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res 51, D523–D531 (2023).
Google Scholar
Polykovskiy, D. et al. Molecular Sets (MOSES): A benchmarking platform for molecular generation models. Front Pharm. 11, 565644 (2020).
Google Scholar
Jin, W. et al. Chapter 11: Junction Tree Variational Autoencoder for Molecular Graph Generation. in RSC Drug Discovery Series vols 2021-January (2021).
Gómez-Bombarelli, R. et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent. Sci. 4, 268–276 (2018).
Google Scholar
Gebauer, N. W. A. et al. Symmetry-adapted generation of 3D point sets for the targeted discovery of molecules. in Advances in Neural Information Processing Systems 32 arXiv preprint arXiv:1906.00957 (2019).
Jerret R. et al. GP-MoLFormer: A Foundation Model For Molecular Generation. (2024).
Sheth, A. et al. Transforming Big Data into Smart Data: Deriving Value via Harnessing Volume, Variety & Velocity Using Semantics and Semantic Web. IEEE Internet Computing 3 (2007).
Irwin, R. et al. Chemformer: a pre-trained transformer for computational chemistry. Mach. Learn Sci. Technol. 3, 015022 (2022).
Google Scholar
Xie, Y. et al. MARS: MARKOV MOLECULAR SAMPLING FOR MULTI-OBJECTIVE DRUG DISCOVERY. in ICLR 2021 – 9th International Conference on Learning Representations (2021).
Guimaraes, G. L. et al. Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models. (2017).
Zhou, Z. et al. Optimization of molecules via deep reinforcement learning. Sci. Rep. 9, 10752 (2019).
Google Scholar
You, J. et al. Graph convolutional policy network for goal-directed molecular graph generation. in Advances in Neural Information Processing Systems vols 2018-December (2018).
Yoshida, M. et al. Using evolutionary algorithms and machine learning to explore sequence space for the discovery of antimicrobial. Pept. Chem. 4, 533–543 (2018).
Google Scholar
Maragakis, P. et al. A deep-learning view of chemical space designed to facilitate drug discovery. J. Chem. Inf. Model 60, 4487–4496 (2020).
Google Scholar
Jin, W. et al. Learning multimodal graph-to-graph translation for molecular optimization. in 7th International Conference on Learning Representations, ICLR 2019 (2019).
Chen, C. H. et al. Simulation-guided rational de novo design of a small pore-forming antimicrobial Peptide. J. Am. Chem. Soc. 141, 4839–4848 (2019).
Google Scholar
Zhu, Y. et al. Deciphering the coevolutionary dynamics of L2 β-Lactamases via Deep Learning. J. Chem. Inf. Model 64, 3706–3717 (2024).
Google Scholar
de la Fuente-Nunez, C. AI in infectious diseases: The role of datasets. Drug Resistance Updates 73, 101067 (2024).
Google Scholar
Medina-Franco, J. L. et al. Bridging informatics and medicinal inorganic chemistry: Toward a database of metallodrugs and metallodrug candidates. Drug Discov. Today 27, 1420–1430 (2022).
Google Scholar
Frei, A. et al. Metals to combat antimicrobial resistance. Nat. Rev. Chem. 7, 202–224 (2023).
Google Scholar
Arora, A. et al. The value of standards for health datasets in artificial intelligence-based applications. Nat. Med 29, 2929–2938 (2023).
Google Scholar
link